Fair trade watchdog Competition Commission of India (CCI) has carried out a search operation at the city office of country’s largest dry-cell battery maker Eveready Industries for an investigation purpose.
The Kolkata-based battery major on Friday said CCI officials ‘visited’ its office three days ago. “The additional DG, CCI did visit our office on August 23 and ascertained in respect of certain business related information of the company and company officials cooperated and responded to all such queries as were raised by him and his staff during such visit,” Eveready said in a clarification sought by the BSE.
“We are awaiting further information from the office of the Additional DG, CCI,” the company said, adding it was not aware about the nature or purpose of the collection of the ‘facts’ by the additional DG, including investigation of the same.
However, according to some media reports, the CCI has ‘raided’ Eveready’s corporate office in Kolkata to investigate alleged “abuse of its dominant position” in dry-cell battery and flashlight markets. When contacted, Eveready Industries’ MD Amritanshu Khaitan said, “It is a regulatory matter, I cannot comment on this.”
Full Content: Financial Express
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
EU and UK Finalize Deal to Strengthen Antitrust Cooperation
May 20, 2025 by
CPI
Clemens Food Group Reaches $13.5 Million Settlement in Pork Price-Fixing Suit
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas